BCIQ Profiles

Company Profile Report
0511 ECP Appia
BioCentury & Getty Images

Emerging Company Profile

Baltimore and colleagues launch NKT cell company Appia 

Emerging Company Profile: Appia emerged from stealth with $52 million and a platform to scale iNKT cell production

Appia emerged from stealth with $52 million and a platform to scale iNKT cell production.

May 11, 2021 | 10:04 PM GMT

As one of the first companies to develop cell therapies based on the rare NKT cell subset, Appia emerged from stealth on Tuesday with a $52 million series A round and a team brought together by Nobel Laureate David

Read the full 928 word article

How to gain access

Continue reading with a
two-week free trial.